Structure vs. Function of TRIB1-Myeloid Neoplasms and Beyond

Area of Science:

• Molecular biology
• Oncology
• Protein biochemistry

Background:

• The Tribbles protein family (TRIB1, TRIB2, TRIB3, STK40) has distinct roles in cellular processes.
• TRIB1 is structurally well-characterized and implicated in various cancers, notably acute myeloid leukemia.
• TRIB1 regulates key pathways like C/EBP transcription factors and kinase signaling.

Purpose of the Study:

• To explore the structural and functional roles of TRIB1 in cancer.
• To investigate TRIB1's mechanism of action in relation to C/EBPα.
• To assess the potential of Tribbles proteins as therapeutic targets or biomarkers.

Main Methods:

• Structure-function studies of TRIB1.
• Analysis of TRIB1's interaction with C/EBPα.
• Examination of TRIB1's role in various cancer types and signaling pathways.

Main Results:

• TRIB1 undergoes conformational switching upon binding to C/EBPα, modulating its activity.
• The active site of TRIB1 is accessible to small-molecule inhibitors, despite lacking ATP-binding ability.
• TRIB1 influences cancer development and chemoresistance across leukemia, glioma, breast, lung, and prostate cancers.

Conclusions:

• TRIB1's structural flexibility and accessible active site present opportunities for small-molecule drug development.
• Tribbles proteins are implicated in diverse oncogenic pathways and chemoresistance.
• Tribbles proteins show promise as therapeutic targets and predictive biomarkers for cancer treatment response.